Correlation Between Capricor Therapeutics and Bolt Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Capricor Therapeutics and Bolt Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Capricor Therapeutics and Bolt Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Capricor Therapeutics and Bolt Biotherapeutics, you can compare the effects of market volatilities on Capricor Therapeutics and Bolt Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Capricor Therapeutics with a short position of Bolt Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Capricor Therapeutics and Bolt Biotherapeutics.
Diversification Opportunities for Capricor Therapeutics and Bolt Biotherapeutics
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Capricor and Bolt is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Capricor Therapeutics and Bolt Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bolt Biotherapeutics and Capricor Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Capricor Therapeutics are associated (or correlated) with Bolt Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bolt Biotherapeutics has no effect on the direction of Capricor Therapeutics i.e., Capricor Therapeutics and Bolt Biotherapeutics go up and down completely randomly.
Pair Corralation between Capricor Therapeutics and Bolt Biotherapeutics
Given the investment horizon of 90 days Capricor Therapeutics is expected to generate 1.51 times more return on investment than Bolt Biotherapeutics. However, Capricor Therapeutics is 1.51 times more volatile than Bolt Biotherapeutics. It trades about 0.07 of its potential returns per unit of risk. Bolt Biotherapeutics is currently generating about -0.03 per unit of risk. If you would invest 401.00 in Capricor Therapeutics on November 2, 2024 and sell it today you would earn a total of 1,085 from holding Capricor Therapeutics or generate 270.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Capricor Therapeutics vs. Bolt Biotherapeutics
Performance |
| Timeline |
| Capricor Therapeutics |
| Bolt Biotherapeutics |
Capricor Therapeutics and Bolt Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Capricor Therapeutics and Bolt Biotherapeutics
The main advantage of trading using opposite Capricor Therapeutics and Bolt Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Capricor Therapeutics position performs unexpectedly, Bolt Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bolt Biotherapeutics will offset losses from the drop in Bolt Biotherapeutics' long position.| Capricor Therapeutics vs. Bio Path Holdings | Capricor Therapeutics vs. NextCure | Capricor Therapeutics vs. Pulmatrix | Capricor Therapeutics vs. Akari Therapeutics PLC |
| Bolt Biotherapeutics vs. Assembly Biosciences | Bolt Biotherapeutics vs. Instil Bio | Bolt Biotherapeutics vs. CytomX Therapeutics | Bolt Biotherapeutics vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |